{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:01:40Z","timestamp":1792152100922,"version":"4.4.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,8,24]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Some 10.1% of adults with non\u2013Langerhans cell histiocytosis have a concomitant myeloid neoplasm with each often harboring distinct mutations. The presence of distinct kinase mutations in histiocytosis and myeloid neoplasms resulted in discordant responses to targeted therapy.<\/jats:p>","DOI":"10.1182\/blood-2017-01-761718","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T21:00:21Z","timestamp":1499288421000},"page":"1007-1013","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":136,"title":["High prevalence of myeloid neoplasms in adults with non\u2013Langerhans cell histiocytosis"],"prefix":"10.1182","volume":"130","author":[{"given":"Matthias","family":"Papo","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne 2, Institut E3M, Centre de R\u00e9f\u00e9rences des Maladies Auto-Immunes et Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Histiocytoses, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli L.","family":"Diamond","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen-Aubart","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne 2, Institut E3M, Centre de R\u00e9f\u00e9rences des Maladies Auto-Immunes et Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Histiocytoses, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"EA4340, Versailles University, Paris-Saclay University, Boulogne, France;"},{"name":"Pathology Service, H\u00f4pital universitaire Ambroise Par\u00e9, AP-HP, Boulogne, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[{"name":"UMR1170, INSERM and Institute Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Durham","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neval","family":"Ozkaya","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[{"name":"Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raajit","family":"Rampal","sequence":"additional","affiliation":[{"name":"Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Foch Hospital, Suresnes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sen\u00e9","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Croix Saint-Simon Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[{"name":"Department of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besnard","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne 2, Institut E3M, Centre de R\u00e9f\u00e9rences des Maladies Auto-Immunes et Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Histiocytoses, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"UMR1170, INSERM and Institute Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Settegrana","sequence":"additional","affiliation":[{"name":"Department of Biological Hematology, University Hospital La Piti\u00e9 Salp\u00eatri\u00e8re, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[{"name":"Gustave Roussy, Paris-Saclay University, Genomic Platform UMS AMMICA, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"H\u00e9lias-Rodzewicz","sequence":"additional","affiliation":[{"name":"EA4340, Versailles University, Paris-Saclay University, Boulogne, France;"},{"name":"Pathology Service, H\u00f4pital universitaire Ambroise Par\u00e9, AP-HP, Boulogne, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne 2, Institut E3M, Centre de R\u00e9f\u00e9rences des Maladies Auto-Immunes et Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Histiocytoses, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[{"name":"Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne 2, Institut E3M, Centre de R\u00e9f\u00e9rences des Maladies Auto-Immunes et Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Histiocytoses, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111904213048900_B1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2019111904213048900_B2","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111904213048900_B3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"19","key":"2019111904213048900_B4","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111904213048900_B5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","article-title":"MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis","volume":"54","author":"Nelson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2019111904213048900_B6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"issue":"20","key":"2019111904213048900_B7","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","article-title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","volume":"123","author":"Nelson","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2019111904213048900_B8","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","article-title":"Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis","volume":"128","author":"Chakraborty","year":"2016","journal-title":"Blood"},{"issue":"15","key":"2019111904213048900_B9","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2015-01-625491","article-title":"Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis","volume":"125","author":"H\u00e9ritier","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111904213048900_B10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","article-title":"Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation","volume":"124","author":"Hervier","year":"2014","journal-title":"Blood"},{"issue":"22","key":"2019111904213048900_B11","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"20","key":"2019111904213048900_B12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"20","key":"2019111904213048900_B13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019111904213048900_B14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"issue":"9","key":"2019111904213048900_B15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111904213048900_B16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111904213048900_B17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamaoncol.2015.0736","article-title":"Vemurafenib use in an infant for high-risk Langerhans cell histiocytosis","volume":"1","author":"H\u00e9ritier","year":"2015","journal-title":"JAMA Oncol"},{"issue":"8","key":"2019111904213048900_B18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations","volume":"373","author":"Hyman","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111904213048900_B19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N Engl J Med"},{"issue":"7287","key":"2019111904213048900_B20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"issue":"24","key":"2019111904213048900_B21","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1208958","article-title":"Progression of RAS-mutant leukemia during RAF inhibitor treatment","volume":"367","author":"Callahan","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111904213048900_B22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/2159-8290.CD-13-1038","article-title":"Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies","volume":"4","author":"Abdel-Wahab","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111904213048900_B23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/2159-8290.CD-14-0742","article-title":"Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders","volume":"5","author":"Hyman","year":"2015","journal-title":"Cancer Discov"},{"issue":"17","key":"2019111904213048900_B24","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.ejca.2012.05.024","article-title":"Incidence, survival and prevalence of myeloid malignancies in Europe","volume":"48","author":"Visser","year":"2012","journal-title":"Eur J Cancer"},{"issue":"6","key":"2019111904213048900_B25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2133.2012.11169.x","article-title":"Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy","volume":"167","author":"Edelbroek","year":"2012","journal-title":"Br J Dermatol"},{"issue":"2","key":"2019111904213048900_B26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mpo.2950230204","article-title":"Acute leukemia in association with Langerhans cell histiocytosis","volume":"23","author":"Egeler","year":"1994","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"2019111904213048900_B27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/mpo.2950210407","article-title":"Langerhans cell histiocytosis and acute leukemia: unusual association in two cases","volume":"21","author":"Aric\u00f2","year":"1993","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"2019111904213048900_B28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0889-8588(05)70516-5","article-title":"The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors","volume":"12","author":"Egeler","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2019111904213048900_B29","first-page":"79","article-title":"Cutaneous Langerhans cell histiocytosis with subsequent development of haematological malignancies. Report of two cases","volume":"15","author":"Wollina","year":"2006","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"issue":"26","key":"2019111904213048900_B30","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111904213048900_B31","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111904213048900_B32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"2019111904213048900_B33","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2019111904213048900_B34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/PAS.0b013e318283099f","article-title":"Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation","volume":"37","author":"West","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2019111904213048900_B35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","article-title":"Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases","volume":"24","author":"Shao","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"2019111904213048900_B36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/1947-2714.114172","article-title":"Langerhans cell sarcoma arising from chronic lymphocytic lymphoma\/small lymphocytic leukemia: lineage analysis and BRAF V600E mutation study","volume":"5","author":"Chen","year":"2013","journal-title":"N Am J Med Sci"},{"issue":"9","key":"2019111904213048900_B37","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3324\/haematol.2009.021212","article-title":"Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans\u2019 cell sarcoma: evidence for hematopoietic plasticity","volume":"95","author":"Ratei","year":"2010","journal-title":"Haematologica"},{"issue":"16","key":"2019111904213048900_B38","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111904213048900_B39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMoa0912228","article-title":"Persistent malignant stem cells in del(5q) myelodysplasia in remission","volume":"363","author":"Tehranchi","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111904213048900_B40","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1073\/pnas.1222861110","article-title":"Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes","volume":"110","author":"Pang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2019111904213048900_B41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2016-02-695312","article-title":"Evolution of acute myelogenous leukemia stem cell properties after treatment and progression","volume":"128","author":"Ho","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2019111904213048900_B42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.2013.181","article-title":"Langerhans cell histiocytosis in acute leukemias of ambiguous or myeloid lineage in adult patients: support for a possible clonal relationship","volume":"27","author":"Yohe","year":"2014","journal-title":"Mod Pathol"},{"issue":"4","key":"2019111904213048900_B43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups [published correction appears in J Exp Med. 2015;212(2):281]","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"issue":"19","key":"2019111904213048900_B44","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/8\/1007\/1404657\/blood761718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/8\/1007\/1404657\/blood761718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:21:54Z","timestamp":1574137314000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/8\/1007\/36950\/High-prevalence-of-myeloid-neoplasms-in-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-761718","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}